Cefepime oral - Nexgen BiosciencesAlternative Names: NB-8947
Latest Information Update: 08 Aug 2016
At a glance
- Originator Nexgen Biosciences
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Bacterial infections
Most Recent Events
- 05 Aug 2016 Investigation in Bacterial infections in USA (PO)